Alberto Berjón

593 total citations
35 papers, 382 citations indexed

About

Alberto Berjón is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Alberto Berjón has authored 35 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Obstetrics and Gynecology and 9 papers in Reproductive Medicine. Recurrent topics in Alberto Berjón's work include Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Sarcoma Diagnosis and Treatment (5 papers). Alberto Berjón is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Sarcoma Diagnosis and Treatment (5 papers). Alberto Berjón collaborates with scholars based in Spain, Finland and United States. Alberto Berjón's co-authors include Marta Mendiola, David Hardisson, Laura Yébenes, Andrés Redondo, Victoria Heredia-Soto, Alicia Hernández, Alejandro Gallego, A Barber, M. Pilar Lostao and Alberto Peláez‐García and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Alberto Berjón

33 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Berjón Spain 12 138 127 93 87 81 35 382
Shigenori Furukawa Japan 12 162 1.2× 138 1.1× 115 1.2× 59 0.7× 64 0.8× 42 449
Qiu Tang China 15 265 1.9× 119 0.9× 156 1.7× 64 0.7× 78 1.0× 35 597
Hsien‐Chang Shih Japan 9 149 1.1× 120 0.9× 43 0.5× 24 0.3× 108 1.3× 10 360
Liping Han China 14 268 1.9× 100 0.8× 220 2.4× 29 0.3× 71 0.9× 30 540
Benoit Destenaves United Kingdom 11 175 1.3× 53 0.4× 96 1.0× 81 0.9× 45 0.6× 15 544
Kazuomi Nakamura Japan 12 241 1.7× 62 0.5× 27 0.3× 25 0.3× 80 1.0× 28 475
Wen‐Ning Fang China 7 211 1.5× 54 0.4× 85 0.9× 109 1.3× 30 0.4× 8 403
John F. Langenheim United States 11 157 1.1× 97 0.8× 93 1.0× 17 0.2× 67 0.8× 21 414
Jason M. Spaeth United States 12 330 2.4× 61 0.5× 53 0.6× 23 0.3× 88 1.1× 17 668
Manuel Vadillo-Buenfil Mexico 11 140 1.0× 96 0.8× 49 0.5× 129 1.5× 11 0.1× 13 578

Countries citing papers authored by Alberto Berjón

Since Specialization
Citations

This map shows the geographic impact of Alberto Berjón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Berjón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Berjón more than expected).

Fields of papers citing papers by Alberto Berjón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Berjón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Berjón. The network helps show where Alberto Berjón may publish in the future.

Co-authorship network of co-authors of Alberto Berjón

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Berjón. A scholar is included among the top collaborators of Alberto Berjón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Berjón. Alberto Berjón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Janeiro, Álvaro, Ignacio Ruz‐Caracuel, Carlos E. de Andrea, et al.. (2025). The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas. Cells. 14(21). 1676–1676.
2.
Mendiola, Marta, Victoria Heredia-Soto, Ignacio Ruz‐Caracuel, et al.. (2024). Performance of the Idylla microsatellite instability test in endometrial cancer. Molecular and Cellular Probes. 77. 101976–101976.
3.
Mendiola, Marta, Jani Saarela, Victoria Heredia-Soto, et al.. (2024). Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma. Biomedicine & Pharmacotherapy. 173. 116397–116397. 1 indexed citations
4.
Gallego, Alejandro, Marta Mendiola, Bárbara Hernando, et al.. (2022). Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer. International Journal of Gynecological Cancer. 32(8). 1009–1016. 10 indexed citations
5.
Ruz‐Caracuel, Ignacio, Victoria Heredia-Soto, Bulat Zagidullin, et al.. (2022). Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?. Cancers. 14(4). 912–912. 5 indexed citations
6.
Heredia-Soto, Victoria, María P. De Miguel, Patricia Ruíz, et al.. (2022). Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models. Frontiers in Oncology. 12. 862321–862321. 2 indexed citations
7.
López‐Janeiro, Álvaro, Ignacio Ruz‐Caracuel, Vivian de los Rı́os, et al.. (2021). Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling. Cancers. 13(4). 794–794. 36 indexed citations
8.
Ruz‐Caracuel, Ignacio, Álvaro López‐Janeiro, Victoria Heredia-Soto, et al.. (2021). Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(6). 1167–1176. 36 indexed citations
9.
Mendiola, Marta, Teijo Pellinen, Alberto Berjón, et al.. (2021). Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer. Modern Pathology. 35(2). 256–265. 17 indexed citations
10.
Heredia-Soto, Victoria, Yinyin Wang, Patricia Ruíz, et al.. (2021). Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?. Cancer Cell International. 21(1). 646–646. 7 indexed citations
11.
Viñal, D., Virginia Martínez-Marín, Alejandro Gallego, et al.. (2020). Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas. Clinical & Translational Oncology. 22(10). 1849–1856. 20 indexed citations
12.
Yébenes, Laura, et al.. (2020). Evaluación de la respuesta patológica a quimioterapia neoadyuvante en cáncer de mama: correlación con el fenotipo molecular. Revista Española de Patología. 54(1). 8–16. 2 indexed citations
13.
Escudero, Francisco, Alberto Berjón, Alicia Hernández, et al.. (2020). 860P Redefining prognosis in early-stage high-grade endometrial cancer. Annals of Oncology. 31. S637–S638. 1 indexed citations
14.
Gallego, Alejandro, Marta Mendiola, Alberto Berjón, et al.. (2020). Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?. Clinical & Translational Oncology. 23(3). 536–542. 5 indexed citations
15.
Ruz‐Caracuel, Ignacio, Álvaro López‐Janeiro, Laura Yébenes, et al.. (2019). Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma. Cancers. 11(12). 1845–1845. 20 indexed citations
16.
Rodríguez, Marta Feito, et al.. (2018). Ulcerated congenital plexiform fibrohistiocytic tumor: Case report and literature review. Pediatric Dermatology. 35(6). e360–e362. 1 indexed citations
17.
Heredia-Soto, Victoria, Marta Mendiola, Daniel Bernabéu, et al.. (2017). AG-120, a novel IDH1 targeted molecule, inhibits invasion and migration of chondrosarcoma cells in vitro. Annals of Oncology. 28. v538–v538. 9 indexed citations
18.
Peláez‐García, Alberto, Laura Yébenes, Alberto Berjón, et al.. (2017). Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer. PLoS ONE. 12(9). e0183452–e0183452. 8 indexed citations
19.
Diestro, María Dolores, Laura Yébenes, Alberto Berjón, et al.. (2016). One-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastasis in endometrial cancer. Gynecologic Oncology. 143(1). 54–59. 28 indexed citations
20.
Orive, Emma, et al.. (1980). Metabolism of nutrients during intestinal absorption in Helix pomatia and Arion empiricorum (Gastropoda: Pulmonata). Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 66(1). 155–158. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigenori Furukawa Breakdown of academic impact, for papers by Qiu Tang Breakdown of academic impact, for papers by Hsien‐Chang Shih Breakdown of academic impact, for papers by Liping Han Breakdown of academic impact, for papers by Benoit Destenaves Breakdown of academic impact, for papers by Kazuomi Nakamura Breakdown of academic impact, for papers by Wen‐Ning Fang Breakdown of academic impact, for papers by John F. Langenheim Breakdown of academic impact, for papers by Jason M. Spaeth Breakdown of academic impact, for papers by Manuel Vadillo-Buenfil
Rankless by CCL
2026